Ticker Details
ProPhase Labs, Inc. ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research and development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.
IPO Date:	May 1, 1994
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.52M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 3.76%
Avg Daily Range (30 D):	$0.02 | 10.57%
Avg Daily Range (90 D):	$0.03 | 9.25%

Institutional Daily Volume
Avg Daily Volume:	.17M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.81M

Trade Size
Avg Trade Size (Sh.):	227
Avg Trade Size (Sh.) (30 D):	2,576
Avg Trade Size (Sh.) (90 D):	146

Institutional Trades
Total Institutional Trades:	10
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$4.5M
Avg Institutional Trade (90 D):	$4.5M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.36M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	12.71K

News

Jan 5, 2026 @ 10:00 AM ProPhase Labs Provides Update on Convertible Debt ... Source: Prophase Labs, Inc.

Aug 13, 2025 @ 1:19 PM ProPhase Labs Posts Narrower Q2 Loss Source: Jesterai

Jun 6, 2025 @ 11:00 AM ProPhase Labs Announces Formation of Clinical Scie... Source: N/A

Nov 8, 2024 @ 4:37 AM ProPhase Labs Announces Pricing of Public Offering... Source: N/A

Aug 7, 2024 @ 1:01 PM Antibody Production Market to Surpass USD 36.49 Bi... Source: Sns Insider

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.78	$-.16
Diluted EPS	$-1.78	$-.16
Revenue	$5.06M	$.88M
Gross Profit	$2.06M	$-.12M
Net Income / Loss	$-41.7M	$-6.84M
Operating Income / Loss	$-29.61M	$-4.76M
Cost of Revenue	$4.07M	$1.01M
Net Cash Flow	$-.1M
PE Ratio

Splits
Dec 22, 2025	1:10